Literature DB >> 25339364

Fixed point observation of etiology of acute liver failure according to the novel Japanese diagnostic criteria.

Keiichi Fujiwara1, Shin Yasui, Yutaka Yonemitsu, Makoto Arai, Tatsuo Kanda, Masayuki Nakano, Shigeto Oda, Osamu Yokosuka.   

Abstract

BACKGROUND: There has existed important differences in the definition of acute liver failure (ALF) between Japanese criteria and those of other countries. The novel diagnostic criteria for ALF in Japanese patients were established by the Intractable Hepato-Biliary Diseases Study Group of Japan, in order to correspond to those for ALF in Europe and the USA. We prospectively diagnosed our ALF patients based on this novel criteria, and discussed the etiology by a fixed point observation.
METHODS: We investigated the etiology of 54 adult inpatients and outpatients with ALF between 2010 and 2012.
RESULTS: Of 54 patients, 36 were ALF without coma, 17 ALF with coma and one late onset hepatic failure. The etiology was due to viral infections in 38.9%, autoimmune hepatitis in 11.1%, drug-induced liver injury in 13.0%, etiologies without hepatitis in 29.6% (circulatory disturbance in 18.5%, infiltration of the liver by malignant cells in 7.4%, and metabolic diseases in 3.7%) and indeterminate causes in 7.4%.
CONCLUSIONS: Circulatory disturbance was the most frequent etiology according to the novel criteria. Indeterminate etiology was less observed in our study than the nation-wide survey with significance (P = 0.0014).
© 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Acute liver failure; Etiology; Fulminant hepatitis; Late onset hepatic failure; Novel Japanese diagnostic criteria

Mesh:

Year:  2014        PMID: 25339364     DOI: 10.1002/jhbp.178

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  1 in total

1.  Galectin‑9 ameliorates fulminant liver injury.

Authors:  Tomoko Tadokoro; Asahiro Morishita; Teppei Sakamoto; Shintaro Fujihara; Koji Fujita; Shima Mimura; Kyoko Oura; Takako Nomura; Joji Tani; Hirohito Yoneyama; Hisakazu Iwama; Takashi Himoto; Toshiro Niki; Mitsuomi Hirashima; Tsutomu Masaki
Journal:  Mol Med Rep       Date:  2017-05-18       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.